Log In
Print
BCIQ
Print
Print this Print this
 

HGT-DEB001

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionIntravenous formulation of recombinant human collagen type VII (COL7A1)
Molecular Target Collagen type VII (COL7A1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard Indication Dermatology (unspecified)
Indication DetailsTreat dystrophic epidermolysis bullosa (DEB)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today